The Impact of National Formulary on Cough Medicine Prescribing in Three Primary Health Care in Depok

    Published on:March 2017
    Journal of Young Pharmacists, 2017; 9(1s):S16-S18
    Original Article | doi:10.5530/jyp.2017.1s.5
    Authors:

    Asma Zahidah, Nanda Asyura Rizkyani, Retnosari Andrajati

    Faculty of Pharmacy, Universitas Indonesia, Gedung A Rumpun Ilmu Kesehatan Lantai 3, Kampus UI Depok, 16424, Jawa Barat, INDONESIA.

    Abstract:

    Objective: To evaluate the use of cough medicine in Acute Respiratory Infections (ARI) patients in three primary health care in Depok in 2015 and suitability with the National Formulary. Method: The study design was descriptive analytic with retrospectively data collection from patient’s prescription, Primary Health Care Management Information System (SIMPUS), and Medicine Management Information System (SIPO). Samples are taken from ARI’s patients prescription from January until December 2015. The analysis was conducted on the prescription that meets the inclusion criteria quantitatively and qualitatively. Quantitative analysis is expressed in DDD and DDD/1000 patients/day. Results: The primary health care that has the biggest quantity of Medicines usage for DDD was in Cipayung (59136, 33g). Then, DDD/1000 patients/day for glyceryl guaiacolate, ambroxol, and dextromethorphan respectively was in Cipayung (14.971g), Limo (1.129 g), and Limo (0,0006g). The primary health care that most suitable with the National Formulary was Conclusion: In conclusion, all the cough medicine use in ARI patients in the three primary health care facilities in Depok in 2015 was unsuitable according to the National Formulary recommendations. Therefore, cough medicine use is needed to be evaluated further.

    Key words: ATC/DDD, Cough, Cough medicine, Depok Primary Health Care, National Fomulary.

    Article Download

     

    SCImago Journal & Country Rank

    Navigation